Related Experiment Video
Updated: Jan 17, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis
Yini Wang1, Junyu Liang2, Jia Wang1
1Department of Rheumatology Immunology and Allergy, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Objectives:
Myositis specific autoantibodies (MSAs) correlate with a distinct clinical phenotype of juvenile dermatomyositis (JDM). This study aims to compare the clinical features of JDM patients with positive anti-NXP2, anti-MDA5 and anti-TIF1γ autoantibodies, and differences in juvenile (JDM) and adult dermatomyositis.
Methods:
This study included 18 NXP2+ JDM patients, 12 MDA5+ JDM patients, 12 TIF1γ+ JDM patients, and 20 NXP2+ adult DM patients. Repeated measures analysis was performed to track longitudinal changes in creatine kinase (CK) levels, Childhood Myositis Assessment Scale (CMAS) scores, and IL-10/γ-interferon ratios. Kaplan-Meier survival and Cox regression analysed relapse rates and recurrence factors.
Results:
NXP2+ JDM patients exhibited significantly elevated serum creatine kinase levels compared to MDA5+ JDM (3792 vs. 180; p<0.001), adult NXP2+DM (3792 vs. 437.5; p=0.003), and TIF1-γ+ JDM (3792 vs. 189; p<0.001). Concurrently, NXP2+ JDM patients also showed lower CMAS scores compared to MDA5+ (31.33 vs. 43.25; p<0.001) and TIF1-γ+ JDM groups (31.33 vs. 42.67; p=0.004). The NXP2+ JDM patients presented with a high frequency of macrophage activation syndrome (MAS), myocardial damage, dysphagia, and calcinosis. Repeated measures analysis showed that NXP2+ JDM patients had more severe muscle damage throughout the disease course compared with MDA5+ JDM patients and TIF1γ+ JDM patients. Furthermore, significant interaction effects of Group and Time on CK were observed in JDM patients. A three-year follow-up study revealed a higher relapse risk in NXP2+ JDM patients compared to MDA5+ JDM, TIF1γ+ JDM and NXP2+ adult DM patients.
Conclusions:
The NXP2+ JDM patients experience more severe muscle damage, systemic complications, and higher relapse risks. Monitoring dynamic changes in CK and CMAS is essential for predicting disease progression and relapse risk.
More Related Videos
10:55Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Myocarditis II: Clinical Features and Diagnostic Tests
Pleiotropy
Desmosomes